Head-to-head · Value Score
CoreAge Rx vs KERNX Health
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, KERNX Health a 80. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameKERNX Health
#60 · Grade B · Good Value
Est. first month
From $129/mo (compounded, plus a one-time consultation fee)
Save ~90% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 80 — an est. $99/mo first month, with no teaser step-up baked in. KERNX Health isn't out of it: Buyers who have been burned by a headline rate that climbed at the second dose increase.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | KERNX Health |
|---|---|---|
| Value Score | 93 (A+) | 80 (B) |
| Est. first month | $99/mo | From $129/mo (compounded, plus a one-time consultation fee) |
| Save vs brand-name | ~89% | ~90% |
| Semaglutide | $99/mo | From $129/mo (compounded, plus a one-time consultation fee) |
| Tirzepatide | $149/mo | From $229/mo (compounded, plus a one-time consultation fee) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
KERNX Health
One of the few compounded sellers that publishes what every dose costs, so the entry price can be checked against the dose you would actually be prescribed.
Why it's a deal
- The advertised entry price survives scrutiny: $129 covers the two lowest semaglutide doses and the whole ladder is published, topping out at $199
- Tirzepatide is priced honestly as a separate, higher ladder — $229 to $329 — instead of being hidden behind the semaglutide headline
- Shipping is included at every dose and there is no membership or platform fee stacked on the plan price
- No multi-month prepayment is required to reach the lowest published rate, which is where most cheap headline prices hide their catch
- Billing does not start until a provider approves treatment, so a declined applicant is not charged for the plan
The fine print
- The one-time consultation fee of $25 to $60 is genuinely extra — a first month at the lowest dose is $154, not $129
- The price you are quoted moves with the dose your provider picks, and dose escalation is normal, so budget the ladder rather than the entry rung
- Never names the pharmacy that compounds the medication, so the fulfillment cost base cannot be sanity-checked
- Cash-pay only, with no insurance billing and lab work charged outside the plan
- No oral or brand-name option, so there is no cheaper or pricier tier to move to within the same provider
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to KERNX Health.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.